Tobacco smoking

Canadian Cancer Society commends tobacco tax and e-cigarette tax increases in federal budget

Retrieved on: 
火曜日, 4月 16, 2024

OTTAWA, ON, April 16, 2024 /CNW/ - The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.

Key Points: 
  • OTTAWA, ON, April 16, 2024 /CNW/ - The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.
  • The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12% effective July 1, 2024.
  • "Increasing tobacco taxes is the most effective strategy to reduce smoking, especially among youth," says Rob Cunningham, Senior Policy Analyst, Canadian Cancer Society (CCS).
  • The tax measures in the budget complement other federal government tobacco control measures including tobacco plain packaging and health warnings, and cost recovery fee legislation for tobacco and vaping companies.

Amwell Expands Presence in Australia with Amplar Health Partnership

Retrieved on: 
水曜日, 2月 21, 2024

Amplar Health partnered with Amwell to support delivery of its prevention programs to reach more Australians at risk of chronic disease.

Key Points: 
  • Amplar Health partnered with Amwell to support delivery of its prevention programs to reach more Australians at risk of chronic disease.
  • Medibank customers will be the first to benefit from the Amplar Health and Amwell partnership, gaining access to a lifestyle management program that will launch soon.
  • Amplar Health will also be an Australian reseller of Amwell Automated Care and the SilverCloud® by Amwell® platforms and embed the technology in its prevention programs and services.
  • “Through our partnership with Amwell, we’re providing innovative resources and support that can help improve health literacy and facilitate better health outcomes for Australians.

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Retrieved on: 
金曜日, 2月 16, 2024

The pre-IND teleconference included representatives from various divisions of the FDA covering all regulatory aspects of the CannQuit-N development program.

Key Points: 
  • The pre-IND teleconference included representatives from various divisions of the FDA covering all regulatory aspects of the CannQuit-N development program.
  • The Agency had reviewed the CannQuit-N meeting package and provided recommendations on key design aspects of the proposed clinical trials, including the timing of efficacy endpoints and specific details on safety endpoints.
  • The FDA also confirmed proposed strategies for manufacturing and quality control are appropriate.
  • The productive discussion with the FDA is an important milestone for the development of CannQuit-N and will guide the continued development of the drug product.

QFG Slams WHO's Latest Report as 'Unscientific'

Retrieved on: 
月曜日, 1月 15, 2024

"The best available clinical and population studies consistently show that vaping has led to adult smoking cessation.

Key Points: 
  • "The best available clinical and population studies consistently show that vaping has led to adult smoking cessation.
  • As a Filipino physician, Dr. Mata said the WHO's failure to differentiate between the risks of e-cigarettes and combustible tobacco is unscientific.
  • This new report perpetuates this tradition, calling for a ban on less risky alternatives while freely allowing the sale of tobacco.
  • However, for over a billion tobacco smokers worldwide, electronic nicotine delivery systems are part of the solution, not the problem," Prof. Britton said.

LUCY ANNOUNCES PUBLICATION OF PEER-REVIEWED BEHAVIORAL STUDY OF ITS NON-MEDICINAL NICOTINE GUM

Retrieved on: 
水曜日, 1月 10, 2024

LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.

Key Points: 
  • LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.
  • Titled " Perceptions, intentions, and actual use of a consumer nicotine gum ," the study is the first to assess the potential of non-medicinal nicotine gum to switch adults who smoke to a potentially less harmful alternative.
  • Lucy's behavioral study in Harm Reduction Journal is first to assess nicotine gum as less harmful smoking alternative.
  • Quitting or cutting down consumption of cigarettes, vapes and other tobacco products were the most common motivation for trying LUCY Gum.

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

Retrieved on: 
木曜日, 12月 7, 2023

According to the World Health Organization , COPD is the third deadliest disease in the world.

Key Points: 
  • According to the World Health Organization , COPD is the third deadliest disease in the world.
  • Today, there are an estimated 480 million people who suffer from COPD.
  • This study in JAMA Network Open projects the increased regional and global burden of COPD by 2050 through an analysis of historical COPD prevalence and data on COPD risk factors such as tobacco smoking, outdoor air pollution, and household air pollution.
  • “The disproportionate growth of COPD among women is a critical finding as COPD has not always been as prevalent in women.

EGFR Tests Market Forecasts to 2033: Comprehensive Analysis of Size, Share, Regulatory Landscape and Global Trends - ResearchAndMarkets.com

Retrieved on: 
金曜日, 12月 22, 2023

The "EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
  • The model includes EGFR Immunohistochemistry Tests, EGFR Sanger Sequencing Tests, EGFR Nucleic Acid Amplification Tests (NAATs), and EGFR Other Tests (EGFR ISH and Mass Array tests).
  • Key Inclusions of the market model are:
    Currently marketed EGFR Tests and evolving competitive landscape:
    Insightful review of the key industry trends.
  • Global, Regional and Country level market specific insights:
    Qualitative market specific information is available with global trends further broken down into regional trends.

New Canadian Cancer Statistics report reveals lung cancer death rates are declining faster than any other cancer type in Canada

Retrieved on: 
水曜日, 11月 8, 2023

The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.

Key Points: 
  • The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.
  • While the age-standardized lung cancer death rates have decreased substantially, an estimated 20,600 people are expected to die from lung cancer (9,800 females and 10,800 males) in Canada in 2023.
  • The most significant reason that lung cancer death rates are improving is due to a reduction in commercial tobacco use, which is the leading risk factor for lung cancer.
  • "By investing more into lung cancer research, we gain critical insights about lung cancer and disease progression that will enable us to develop better treatments for lung cancer patients."

National Survey Shows Drop in E-Cigarette Use Among High School Students

Retrieved on: 
木曜日, 11月 2, 2023

SILVER SPRING, Md., Nov. 2, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), released data from the 2023 National Youth Tobacco Survey (NYTS) on tobacco product use among U.S. youth. The findings, which were collected between March and June 2023, show that 10% of U.S. middle and high school students (2.8 million youth) reported current use of any tobacco product.

Key Points: 
  • Among U.S. high school students, current overall tobacco product use declined during 2022-2023 (16.5% to 12.6%).
  • Among high school students, declines in current use were also observed during 2022-2023 for cigars and overall combustible tobacco smoking, representing all-time lows.
  • Although a decrease in e-cigarette use was observed among high school students, among middle school students there was an increase in current overall tobacco product use (4.5% to 6.6%) and multiple tobacco product use (1.5% to 2.5%).
  • E-cigarettes remained the most commonly used tobacco product among both high school and middle school students for the 10th year in a row.

Smoke Free Sweden: Health Experts Condemn ‘Backward’ Ban on Lifeline for Smokers

Retrieved on: 
水曜日, 9月 13, 2023

Dr. Human continued, “Around the world, alternative nicotine products are helping to save millions of lives by giving smokers an escape from combustible cigarettes.

Key Points: 
  • Dr. Human continued, “Around the world, alternative nicotine products are helping to save millions of lives by giving smokers an escape from combustible cigarettes.
  • They are proven to be at least 95% less harmful than cigarettes and the most effective way for smokers to quit.
  • “Sweden is leading the way for other nations, such as the United Kingdom where the health service is giving free vape kits to smokers to help them quit.
  • Smoke Free Sweden is led by Health Diplomats, a global network of public health experts committed to developing and delivering solutions to global health-related problems.